Sedation and paralysis

Respiratory Care

Volumn 58, Issue 6, 2013, Pages 1024-1035

  Piriyapatsom, Annop ^a   Bittner, Edward A ^a   Hines, Jessica ^a   Schmidt, Ulrich H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Critical illness; Mechanical ventilation; Neuromuscular blocking agent; Sedation; Sedatives

Indexed keywords

1 HYDROXYMIDAZOLAM GLUCURONIDE; AMINOSTEROID; ANALGESIC AGENT; ATRACURIUM BESILATE; BENZODIAZEPINE DERIVATIVE; BENZYLISOQUINOLINE DERIVATIVE; CISATRACURIUM; CORTICOSTEROID; DEXMEDETOMIDINE; DRUG METABOLITE; LAUDANOSINE; LORAZEPAM; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PANCURONIUM; PLACEBO; PROPOFOL; ROCURONIUM; SEDATIVE AGENT; UNCLASSIFIED DRUG; VECURONIUM;

ACUTE KIDNEY FAILURE; ALGORITHM; ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANXIETY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BAROTRAUMA; BISPECTRAL INDEX; BOLUS INJECTION; BRADYCARDIA; CARDIOVASCULAR DISEASE; CHOLESTASIS; CLINICAL PROTOCOL; COGNITIVE DEFECT; COMA; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DEEP SEDATION; DELIRIUM; DIAPHRAGMATIC ATROPHY; DRUG ACCUMULATION; DRUG BINDING; DRUG CHOICE; DRUG CLEARANCE; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG MONITORING; DRUG PENETRATION; DRUG POTENCY; DRUG RESPONSE; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TRANSFORMATION; EVIDENCE BASED MEDICINE; EXTUBATION; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HISTAMINE RELEASE; HOSPITAL INFECTION; HUMAN; HYPERAMYLASEMIA; HYPERCAPNIA; HYPERKALEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INFECTION RISK; INOTROPISM; INTENSIVE CARE; INTENSIVE CARE UNIT ACQUIRED WEAKNESS; MENTAL DISEASE; METABOLIC ACIDOSIS; MUSCLE DISEASE; NONHUMAN; PAIN; PARALYSIS; PATIENT MONITORING; POLYNEUROPATHY; POSITIVE END EXPIRATORY PRESSURE; POSTTRAUMATIC STRESS DISORDER; PROPOFOL INFUSION SYNDROME; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; RHABDOMYOLYSIS; RICHMOND AGITATION SEDATION SCALE; RISK FACTOR; SEDATION; SEIZURE; SELF REPORT; SIDE EFFECT; SINGLE DRUG DOSE; SINUSITIS; STRUCTURE ANALYSIS; TACHYCARDIA; TIDAL VOLUME; TRANQUILIZING ACTIVITY; UNSPECIFIED SIDE EFFECT; UPPER GASTROINTESTINAL BLEEDING; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR BINDUCED DIAPHRAGMATIC DYSFUNCTION; WEAKNESS;

CRITICAL ILLNESS; MECHANICAL VENTILATION; NEUROMUSCULAR BLOCKING AGENT; SEDATION; SEDATIVES;

ALGORITHMS; CRITICAL ILLNESS; DEEP SEDATION; DRUG MONITORING; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; NEUROMUSCULAR BLOCKING AGENTS; PARALYSIS; RESPIRATION, ARTIFICIAL; VENTILATOR WEANING;

EID: 84878423467     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02232     Document Type: Article

References (105)

1. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30(1):119-141.
2. Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med 2012;185(5):486-497.
3. McGrane S, Pandharipande PP. Sedation in the intensive care unit. Minerva Anestesiol 2012;78(3):369-380.
4. Brush DR, Kress JP. Sedation and analgesia for the mechanically ventilated patient. Clin Chest Med 2009;30(1):131-141.
5. Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001;29(2):277-282.
6. Nseir S, Makris D, Mathieu D, Durocher A, Marquette CH. Intensive care unit-acquired infection as a side effect of sedation. Crit Care 2010;14(2):R30.
7. Banerjee A, Girard TD, Pandharipande P. The complex interplay between delirium, sedation, and early mobility during critical illness: applications in the trauma unit. Curr Opin Anaesthesiol 2011; 24(2):195-201.
8. Jones SF, Pisani MA. ICU delirium: an update. Curr Opin Crit Care 2012;18(2):146-151.
9. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007;33(1):66-73.
10. Treggiari MM, Romand JA, Yanez ND, Deem SA, Goldberg J, Hudson L, et al. Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med 2009;37(9):2527-2534.
11. Samuelson K, Lundberg D, Fridlund B. Memory in relation to depth of sedation in adult mechanically ventilated intensive care patients. Intensive Care Med 2006;32(5):660-667.
12. Kress JP, Gehlbach B, Lacy M, Pliskin N, Pohlman AS, Hall JB. The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med 2003;168(12): 1457-1461.
13. Samuelson KA, Lundberg D, Fridlund B. Stressful experiences in relation to depth of sedation in mechanically ventilated patients. Nurs Crit Care 2007;12(2):93-104.
14. Mascia MF, Koch M, Medicis JJ. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med 2000;28(7): 2300-2306.
15. Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg 2010;111(2):451-463.
16. Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault PF, et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 2006;34(6):1691-1699.
17. De Jonghe B, Bastuji-Garin S, Fangio P, Lacherade JC, Jabot J, Appere-De-Vecchi C, et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med 2005;33(1):120-127.
18. Quenot JP, Ladoire S, Devoucoux F, Doise JM, Cailliod R, Cunin N, et al. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007; 35(9):2031-2036.
19. Elliott R, McKinley S, Aitken LM, Hendrikz J. The effect of an algorithm-based sedation guideline on the duration of mechanical ventilation in an Australian intensive care unit. Intensive Care Med 2006;32(10):1506-1514.
20. Jackson DL, Proudfoot CW, Cann KF, Walsh T. A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care 2010;14(2):R59.
21. Mehta S, Burry L, Cook D, Fergusson D, Steinberg M, Granton J, et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA 2012;308(19):1985-1992.
22. Sessler CN, Grap MJ, Ramsay MA. Evaluating and monitoring analgesia and sedation in the intensive care unit. Crit Care 2008; 12(Suppl 3):S2.
23. Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bürkle H, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care: short version. Ger Med Sci 2010;8:Doc02.
24. Payen JF, Bru O, Bosson JL, Lagrasta A, Novel E, Deschaux I, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001;29(12):2258-2263.
25. Odhner M, Wegman D, Freeland N, Steinmetz A, Ingersoll GL. Assessing pain control in nonverbal critically ill adults. Dimens Crit Care Nurs 2003;22(6):260-267.
26. Gélinas C, Fillion L, Puntillo KA, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 2006;15(4):420-427.
27. Ogilvie MP, Pereira BM, Ryan ML, Gomez-Rodriguez JC, Pierre EJ, Livingstone AS, et al. Bispectral index to monitor propofol sedation in trauma patients. J Trauma 2011;71(5):1415-1421.
28. Turkmen A, Altan A, Turgut N, Vatansever S, Gokkaya S. The correlation between the Richmond agitation-sedation scale and bispectral index during dexmedetomidine sedation. Eur J Anaesthesiol 2006;23(4):300-304.
29. Doi M, Morita K, Mantzaridis H, Sato S, Kenny GN. Prediction of responses to various stimuli during sedation: a comparison of three EEG variables. Intensive Care Med 2005;31(1):41-47.
30. Deogaonkar A, Gupta R, DeGeorgia M, Sabharwal V, Gopakumaran B, Schubert A, et al. Bispectral Index monitoring correlates with sedation scales in brain-injured patients. Crit Care Med 2004; 32(12):2403-2406.
31. Tonner PH, Wei C, Bein B, Weiler N, Paris A, Scholz J. Comparison of two bispectral index algorithms in monitoring sedation in postoperative intensive care patients. Crit Care Med 2005;33(3): 580-584.
32. Vivien B, Di Maria S, Ouattara A, Langeron O, Coriat P, Riou B. Overestimation of Bispectral Index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiology 2003;99(1):9-17.
33. Lu CH, Man KM, Ou-Yang HY, Chan SM, Ho ST, Wong CS, et al. Composite auditory evoked potential index versus bispectral index to estimate the level of sedation in paralyzed critically ill patients: a prospective observational study. Anesth Analg 2008;107(4):1290-1294.
34. Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009;37(12):3031-3039.
35. Hewson-Conroy KM, Burrell AR, Elliott D, Webb SA, Seppelt IM, Taylor C, et al. Compliance with processes of care in intensive care units in Australia and New Zealand: a point prevalence study. Anaesth Intensive Care 2011;39(5):926-935.
36. Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin 2009;25(3):431-449.
37. Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol 2004;57(2):135-145.
38. McCollam JS, O'Neil MG, Norcross ED, Byrne TK, Reeves ST. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med 1999;27(11):2454-2458.
39. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A doubleblind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001;95(2):286-298.
40. Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006;104(1):21-26.
41. Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001;95(2):324-333.
42. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, Cuena-Boy R, Castellano-Hernandez M. Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 2001; 29(2):317-322.
43. Knibbe CA, Naber H, Aarts LP, Kuks PF, Danhof M. Long-term sedation with propofol 60 mg mL(-1) vs propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients. Acta Anaesthesiol Scand 2004;48(3):302-307.
44. Nanas S, Angelopoulos E, Tsikriki S, Kritikos K, Voutsinas E, Zervakis D, et al. Propofol-induced hyperamylasaemia in a general intensive care unit. Anaesth Intensive Care 2007;35(6):920-923.
45. Otterspoor LC, Kalkman CJ, Cremer OL. Update on the propofol infusion syndrome in ICU management of patients with head injury. Curr Opin Anaesthesiol 2008;21(5):544-551.
46. Fudickar A, Bein B. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol 2009;75(5): 339-344.
47. Hall RI, Sandham D, Cardinal P, Tweeddale M, Moher D, Wang X, et al. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001;119(4):1151-1159.
48. Carson SS, Kress JP, Rodgers JE, Vinayak A, Campbell-Bright S, Levitt J, et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 2006;34(5):1326-1332.
49. Ho KM, Ng JY. The use of propofol for medium and long-term sedation in critically ill adult patients: a meta-analysis. Intensive Care Med 2008;34(11):1969-1979.
50. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009;25(3):451-469;vii.
51. De Wolf AM, Fragen RJ, Avram MJ, Fitzgerald PC, Rahimi-Danesh F. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001;93(5):1205-1209.
52. Iirola T, Ihmsen H, Laitio R, Kentala E, Aantaa R, Kurvinen JP, et al. Population pharmacokinetics of dexmedetomidine during longterm sedation in intensive care patients. Br J Anaesth 2012;108(3): 460-468.
53. Precedex: full prescribing information. Lake Forest, IL: Hospira; Revised September 2010:EN-2680. http://www.precedex.com/ wp-content/uploads/Precedex_PI.pdf. Accessed March 21, 2013.
54. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004;30(12):2188-2196.
55. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298(22):2644-2653.
56. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010; 14(2):R38.
57. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301(5):489-499.
58. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012;307(11):1151-1160.
59. Dasta JF, Kane-Gill SL, Pencina M, Shehabi Y, Bokesch PM, Wisemandle W, et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010;38(2):497-503.
60. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114(2):541-548.
61. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000;342(20):1471-1477.
62. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 2004; 32(6):1272-1276.
63. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008;371(9607):126-134.
64. Jackson JC, Girard TD, Gordon SM, Thompson JL, Shintani AK, Thomason JW, et al. Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med 2010;182(2):183-191.
65. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373(9678):1874-1882.
66. Pohlman MC, Schweickert WD, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation. Crit Care Med 2010;38(11):2089-2094.
67. Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010;375(9713):475-480.
68. Marini JJ. Spontaneously regulated vs controlled ventilation of acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2011;17(1):24-29.
69. Gama de Abreu M, Guldner A, Pelosi P. Spontaneous breathing activity in acute lung injury and acute respiratory distress syndrome. Curr Opin Anaesthesiol 2012;25(2):148-155.
70. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med 2010;363(12):1176-1180.
71. Sessler CN. Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation. Crit Care Med 2005;33(3 Suppl):S209-S216.
72. Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L, et al. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005;128(2):496-506.
73. Raoof S, Goulet K, Esan A, Hess DR, Sessler CN. Severe hypoxemic respiratory failure: part 2: nonventilatory strategies. Chest 2010;137(6):1437-1448.
74. Schmidt UH, Hess DR. Does spontaneous breathing produce harm in patients with the acute respiratory distress syndrome? Respir Care 2010;55(6):784-786.
75. Schmidt U, Coppadoro A, Hess DR. To breathe or not to breathe? Crit Care Med 2012;40(5):1680-1681.
76. Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW, Jr., Tescher AN, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30(1):142-156.
77. Warr J, Thiboutot Z, Rose L, Mehta S, Burry LD. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Ann Pharmacother 2011;45(9):1116-1126.
78. Arroliga AC, Thompson BT, Ancukiewicz M, Gonzales JP, Guntupalli KK, Park PK, et al. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2008;36(4): 1083-1088.
79. Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996;153(5):1686-1690.
80. Behbehani NA, Al-Mane F, D'Yachkova Y, Pare P, FitzGerald JM. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 1999; 115(6):1627-1631.
81. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27(8):1288-1296.
82. Murray MJ, Brull SJ, Bolton CF. Brief review: nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anaesth 2006;53(11):1148-1156.
83. Brunello AG, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM. Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Med 2010;36(1):66-74.
84. de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001;29(12):2281-2286.
85. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288(22):2859-2867.
86. Ali NA, O'Brien JM, Jr., Hoffmann SP, Phillips G, Garland A, Finley JC, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178(3):261-268.
87. Petrof BJ, Jaber S, Matecki S. Ventilator-induced diaphragmatic dysfunction. Curr Opin Crit Care 2010;16(1):19-25.
88. Tobin MJ, Laghi F, Jubran A. Narrative review: ventilator-induced respiratory muscle weakness. Ann Intern Med 2010;153(4):240-245.
89. Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008;358(13):1327-1335.
90. Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006;34(11):2749-2757.
91. Gainnier M, Roch A, Forel JM, Thirion X, Arnal JM, Donati S, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004;32(1):113-119.
92. Marik PE, Kaufman D. The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Chest 1996;109(4):1038-1042.
93. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107-1116.
94. Marsch SC, Steiner L, Bucher E, Pargger H, Schumann M, Aebi T, et al. Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial. Crit Care 2011;15(4):R199.
95. Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol 2002;19(7):466-473.
96. Vender JS, Szokol JW, Murphy GS, Nitsun M. Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 2004;32(11 Suppl):S554-S561.
97. Sessler CN. Train-of-four to monitor neuromuscular blockade? Chest 2004;126(4):1018-1022.
98. Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ Jr, et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995;81(1):3-12.
99. Neto AS, Pereira VG, Esposito DC, Damasceno MC, Schultz MJ. Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care 2012;2(1):33.
100. Derrington MC, Hindocha N. Measurement of evoked diaphragm twitch strength during anaesthesia. Adaptation and evaluation of an existing technique. Br J Anaesth 1988;61(3):270-278.
101. Donati F, Antzaka C, Bevan DR. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1986;65(1):1-5.
102. Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J, Jr., Hyzy R, et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 1997;25(4):575-583.
103. Baumann MH, McAlpin BW, Brown K, Patel P, Ahmad I, Stewart R, et al. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Chest 2004;126(4):1267-1273.
104. Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y. Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med 2012;40(5):1578-1585.
105. Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41(1):263-306.